Introduction A ntioxidative and redox systems constitute defense mechanisms against the oxidation accompanying vital activity and diseased conditions, and their dysfunction causes oxidative stress that exacerbates various injuries. Glutathione is the most abundant nonprotein thiol in cells and plays pleiotropic roles among many low molecular weight antioxidants and redox molecules.
(1) Antioxidative functions of glutathione are expressed by either direct interaction with reactive oxygen species (ROS) or the donation of electrons to other redox systems, such as glutathione peroxidase (GPX) and glutaredoxin (Grx). (2) In addition to antioxidation and electron donation, glutathione is required for maintaining homeostasis in animals, such as detoxification, by forming conjugation with toxicants and suppression of apoptosis. (3, 4) Glutathione is present in either the reduced form (GSH) or an oxidized form (GSSG) where two molecules are linked by a disulfide bond. The redox balance of glutathione affects cellular homeostasis. Glutathione is also required for ROS-mediated intracellular signal transduction by maintaining redox potential within cells, because reactive protein thiols that can exist only under a reducing environment are general acceptors of the ROS signal.
(5) Levels of glutathione are maintained by de novo synthesis from constituent amino acids, Glu, Cys and Gly, and by the recycling of GSSG (Fig. 1) . De novo synthesis of glutathione is catalyzed by two enzymes, γ-glutamylcysteine synthetase (γ-GCS) and glutathione synthetase (GSS).
(1) Oxidized glutathione is either recycled by glutathione reductase (GSR) using NADPH provided largely from the pentose phosphate pathway (PPP) or exported by multidrug resistance protein (MRP). (6) Glutathione conjugates of xenobiotic compounds and S-nitrosoglutathione (GSNO) are also exported out of the cells and ultimately excreted by the kidney. Transnitrosylation from GSNO in blood plasma is involved in vasodilation and cardioprotection. (7) Knowledge of the roles of glutathione in living animals has been limited due to the difficulty in handling gene expression and, hence, the metabolic process. On the other hand, in vitro studies face limitations in understanding the physiologic functions of glutathione because most experiments are performed under a culture with atmospheric oxygen (~21%), which is about one order higher than in vivo oxygen conditions (2-5%). Oxidative stress occurs chronically in cells cultured under atmospheric oxygen and, hence, may be a cause for inconsistency from in vivo studies.
Advanced technology in establishing genetically modified animals enabled us to elucidate the roles of individual genes in the body. This manuscript is an overview of the progress made thus far in understanding glutathione homeostasis and the in vivo roles of the genes involved in glutathione metabolism.
Pleiotropic Functions of Glutathione
Glutathione was discovered more than 100 years ago, but researchers continue to experiment with this tripeptidyl molecule. While intracellular cysteine concentrations are kept low (several μM) due to a cellular toxicity that is caused by the interaction of A cysteine with pyridoxal-5'-phosphate, a cofactor for amino grouptransferring enzymes, glutathione present in the millimolar range is a main compound for the maintenance of redox potential within cells. Glutathione exerts its multiple functions by two means: non-enzymatic and enzymatic reactions. Brief mentions of these follow.
Non enzymatic reaction of glutathione. GSH and ascorbate are major antioxidants with a strong reducing ability. The direct ROS-scavenging function of GSH can be well characterized by this chemical reaction. In fact, the pKa of a sulfhydryl group of glutathione is comparable to that of cysteine, around 8.5-8.8, and is not a very effective ROS scavenger. (8) Its presence in high concentrations within cells (~10 mM) exerts a potential function as an ROS scavenger and an anti-apoptotic compound in cells by reducing oxidized cytochrome c. (9, 10) The sulfhydryl group of glutathione, as with protein sulfhydryls, suffers from various oxidative and nitrosative modifications. The oxidation of a sulfhydryl to sulfenic acid is fully reversible; that of sulfenic acid to sulfinic acid is partly reversible, as can be seen in the sulfiredoxin system; however, the reaction whereby sulfinic acid converts to sulfonic acid is irreversible (Fig. 2) . (11) Electron donation from radicals, such as a superoxide or a hydroxyl radical, produces a thiyl radical, which is highly reactive to other sulfhydryls, and, consequently, glutathionylates proteins as well as GSSG (Fig. 3) . (12) The interaction of glutathione with sulfhydryls in oxidatively modified proteins also causes protein Sglutathionylation, a mixed disulfide between Cys-SH of protein and glutathione. In normal liver, around 1% of total glutathione appears to be constantly present as the mixed disulfide with proteins, and the amount of glutathione bound to proteins could increase by 20-50% depending on the cellular redox state. (13, 14) While glutathionylation consumes GSH in the cytoplasm and results in a redox imbalance within cells, dysfunction occurs to the glutathionylated proteins. A glutathionylated protein can be reduced back to sulfhydryl by Grx, which transiently result in glutathionylated Grx. The glutathione moiety of Grx can be freed by another glutathione to form GSSG, while Grx returns to its initial reduced form. (15) The reaction involving reversible glutathionylation is used for the protective mechanism of essential sulfhydryls in proteins under oxidative stress. This particular protective mechanism by glutathionylation has attracted much recent attention. (16) The interaction of glutathione with nitric oxide (NO) produces GSNO that constitutes a major nitrosothiol in plasma, as well as in cells. While GSNO exerts multiple functions, such as vasodilatation and signal transduction via transnitrosation, it is also regarded as an effective glutathionylating agent. (17, 18) Several Fig. 1 . Roles and metabolism of glutathione. γ GCS and GSS coordinately catalyze de novo synthesis of GSH from three amino acids: Cys, Glu, and Gly. GPX reduces various peroxides, including hydrogen peroxide, by electrons from GSH. The resultant GSSG is reduced back to GSH by GSR via the donation of electrons from NADPH supplied from the pentose phosphate pathway (PPP). GSH not only supplies electrons to peroxides, but also plays multiple roles in cells.
Fig. 2.
Oxidative conversion of the sulfhydryl group and its reversibility in cells. Other than disulfide, the sulfhydryl group forms three oxidation states: sulfenic, sulfinic, and sulphonic acid. Sulenic acid can be reduced back to sulfhydryl by reductases but forms a disulfide bond with another sulfhydryl group. It was a general understanding that sulfinic acid could not be reduced back to sulfhydryl until the discovery of sulphiredoxin.
methods can be used to detect glutathionylation; e.g., radio-labeling with [
35 S]cysteine, glutathione S-transferase, and anti-glutathione antibody. (19, 20) Advances in the proteomic approach that are based upon the separation of proteins by two-dimensional gel electrophoresis followed by identification by mass spectrometry have enabled the efficient detection of glutathionylated proteins with a high degree of reliability. This methodology has made it possible to detect glutathionylated proteins as well as other modifications in vivo, and has enhanced the understanding of their roles in the physiological state.
Enzymatic reactions utilizing glutathione as a co substrate. Glutathione is also an electron donor for enzymatic systems using GPX. Electrons from glutathione are used to reduce various peroxides by GPX. (21) Conventional GPX constitutes 4 members and contains selenocysteine as the catalytic center. Since replacement of the selenocysteine to cysteine shows much lower GPX activity, the high catalytic activity of GPX can be attributed to the selenocysteine residue in the catalytic center. Current understanding of GPX family genes is overviewed elsewhere in this serial review.
In addition to conventional GPX, other enzymes such as glutathione S-transferase (GST), also exhibit glutathione-dependent peroxidase activity, albeit with much less efficiency. In addition to ROS scavenging activity, GST catalyzes the formation of glutathione adduct with various biological molecules and functions in the detoxification of xenobiotic compounds. (22) Mice have been generated with deficiencies of mGSTP1/2, mGSTA4-4, mGSTZ1-1, mGSTM1-1, mGSTO1-1 and mGSTS1-1,6 out of 21 GST genes, but the details are not provided here, because an extensive overview of the phenotypes is available in the toxicological report. (23) Glutathione is also used as a building block of leukotriene (LT), which is a lipid mediator triggering various physiological responses. LTC4 synthase conjugates LTA4 with glutathione to form LTC4, (24) which is then converted to LTD4, a cysteinyl leukotriene, by hydrolytic removal of glutamate and glycine by a family member of γ-glutamyltransferase, as described below. Thus, in this case glutathione functions as a cysteine donor to form cysteinyl leukotrienes (Fig. 4) .
Genes Involved in Glutathione Metabolism
The rate-determining, first step of glutathione synthesis is catalyzed by γ-GCS, which forms γ-glutamylcysteine by ligating glutamate and cysteine using ATP. γ-GCS is a heterodimeric enzyme composed of a catalytic subunit encoded by GCLC and a modifier subunit encoded by GCLM. Buthionine sulfoximine (BSO) is a specific inhibitor of the enzyme.
(1)
Genes involved in glutathione metabolism, xCT, GCLM, GCLC, and GSR are induced under oxidative stress in an Nrf2-dependent manner. (25) (26) (27) (28) Since disorders related to glutathione synthesis and pathological phenotypes in humans are well documented, (29, 30) they are only briefly described here. While deficiencies of γ-GCS and GGT are very rare, GSS deficiency is the more frequent disorder. There are several reports concerning the mutation of GLCL. (31) (32) (33) (34) (35) (36) (37) Decreased glutathione levels and hemolytic anemia are commonly observed in γ-GCS and GSS deficiencies.
Mouse models for glutathione deficiency have been well documented. (38) However, roles of the genes in glutathione metabolism have been reconsidered by focusing on the progress that is reviewed here, because significant advances have been made in this area.
Import of cysteine and cystine into cells. Since cysteine exerts toxic effects by binding pyridoxial-5-phosphate (PLP), a cofactor for amino group-transferring enzyme reactions, the intracellular cysteine level is restricted (Fig. 5A ) and is much less than glutamate and glycine. Thus, cysteine availability determines the synthesis of glutathione in cells. Under oxidative stress caused by acetaminophen-induced hepatotoxicity, the augmented production of ophthalmate-with a concomitant decrease of glutathione-can be observed by metabolomic analysis. (39) Ophthalmate is synthesized when 2-aminobutyrate is used in place of cysteine due to structural similarity through consecutive reactions catalyzed by γ-GCS and GSS (Fig. 5B) . Thus, either glutathione or ophthalmate would be an alternative product for γ-GCS and GSS reactions depending on cysteine availability.
Cysteine is synthesized in humans from methionine but is not sufficient for the requirements of glutathione synthesis in most . GGT5 catalyzed LTD4 formation using GSH followed by conver sion to LTE4. cells, because methionine is an essential amino acid and is present only in a limited amount. Thus, cysteine availability sometimes limits glutathione synthesis, especially under oxidative stress that requires prompt glutathione synthesis. Cysteine and its oxidized form, cystine, are imported into cells via several amino acid transport systems. (40) Neutral amino acid transporters uptake cysteine in either a Na + -dependent or -independent manner, while cystine is taken up by the cystine/glutamate exchanging transport system, designated as system xc − , in exchange for glutamate and by b 0,+ in a Na + -independent manner. In a cell culture system, cysteine is spontaneously auto-oxidized to cystine by oxygen, which is then taken up via system xc − . Once cystine is entered into cells, it is simultaneously reduced to cysteine and is utilized for glutathione synthesis as well as protein synthesis. Thus, system xc − activity indirectly controls intracellular glutathione availability in various cells in culture.
(41) System xc − is composed of two proteins, xCT and 4F2hc, and the transport activity of xc − is attributed to the xCT protein. (42) The xCT −/− mice have higher concentrations of cystine in plasma compared with their wild-type littermates, but are otherwise apparently healthy.
A precise description of xCT and its physiological relevance is accorded a special section in this serial review.
Deficiency of γ glutamyl cysteine synthetase (γ GCS).
GCLC-deficient mice have been generated by two groups. (44, 45) The GLCL-null mutant mice are embryonic lethal due to apoptotic cell death. (44) GCLC +/− mice exhibit 20% diminution in GSH levels and a compensatory increase (about 30%) in ascorbate.
(45) GCLCnull cells isolated from embryos die but can survive by supplementation with glutathione (2.5 mM) or N-acetylcysteine (NAC) (1.25-5 mM) in culture media. (44) Rapid onset of steatosis with mitochondrial injury accompanying decreased ATP and increased lipid peroxidation is observed in mice that lack GCLC in a hepatocyte-specific manner.
(46) GCLC-knockdown rats and cells are established using short hairpin RNA against GCLC, and are used to evaluate drug-induced hepatotoxicity. (47, 48) GCLM null mice are viable and fertile and have no overt pheno- type, but levels of glutathione comprise 9-16% of the liver, lung, pancreas, erythrocytes, and plasma of wild-type mice.
(49) MEF isolated from GCLM null mice are highly sensitive to oxidants such as hydrogen peroxide and arsenic. (49, 50) GCLM null mice are also sensitive to acetaminophen-induced liver damage and are protected by administered NAC.
(51) GCLM null mice are sensitive to domoic acid, the causative agent for amnesic shellfish poisoning by mussels, which causes a rapid decrease in cellular glutathione by accelerating efflux from the cells, increases ROS and lipid peroxidation, and induces apoptotic cell death. (52, 53) While compounds that increase cellular glutathione, such as curucumin, quercetin, and tert-butylhydroquinone, induce GCLM much more than GCLC, they fail to increase γ-GCS activity and glutathione levels in GCLM null mice, (54) suggesting an essential role for GCLM in the upregulation of γ-GCS activity. Moreover, early onset of senescence, which is characterized by diminished cellular proliferation and increased senescence, which is associated with β-galactosidase activity, is evident in GCLM-null fibroblasts.
(55) These characteristics are accompanied by an increase in intracellular ROS. Administration of NAC increases glutathione levels and concomitantly prevents premature senescence, suggesting that an increased redox potential attributed to an elevated glutathione can delay cell aging. Moreover, transgenic expression of GCLM increases resistance to acetaminophen-induced liver damage in mice (56) and hydrogen peroxide-induced single-strand DNA breakage in cells. (57) Deficiency of glutathione synthetase. GSS deficiencies are seen more frequently in patients than either GCLC or GCLM deficiencies, but fewer than 100 have been documented worldwide, which defines them as rare genetic disorders. (29) The patients show 5-oxoprolineuria, hemolytic anemia, and neurological dysfunction.
(58,59) About one-third of all patients with this condition die in childhood due to acidosis, electrolyte imbalance, infections, and convulsions. Examination of metabolites in cultured fibroblasts from 9 patients indicates that decreased glutathione and increased cysteine and γ-glutamylcysteine. (60) Since cysteine and γ-glutamylcysteine can partly compensate for the roles of glutathione, this indicates that γ-glutamylcysetine, the product of γ-GCS and a substrate of GSS, accumulates and would compensate redox potential with its sulfhydryl moiety. Hydrolysis of γ-glutamylcysteine by γ-glutamyl cyclotransferase, which was recently identified, (61) produces 5-oxoproline and cysteine. Clarification of the pathogenesis of a GSS deficiency would require the establishment of an animal model and precise analysis.
Recycling oxidized glutathione by glutathione reduc tase. Glutathione reductase (GSR) is a homodimeric flavoprotein (55-kDa each subunit) that regulates cellular GSH homeostasis by catalyzing the reduction of GSSG to GSH using NADPH as a reducing cofactor (Fig. 1) . Anticancer agent 1,3-bis(2-chloroethyl)-1-nitorsourea (BCNU) is a well-known inhibitor for GSR and is used to examine the roles of the enzyme. GSR is predominantly present in liver and erythrocytes and is also expressed at high levels in the epithelia of the lungs (62) and in the reproductive organs of both sexes. (63, 64) Until now, there has been no report regarding the generation of GSR knockout mice by a gene-targeting technique. However, Gr1 a1Neu mice are a strain that is generated by treating male mice with a mutagen, isopropyl methanesulfonate, that exhibits less than 10% GSR activity in liver compared with control mice. (65) Sequence analysis of the GSR shows the deletion involves nucleotides 10,840 through 23,627 of the genomic DNA corresponding to deletion of exons 2 through 5. The deletion also causes a frame shift in exon 6 and introduces premature stop codon in exon 7. Thus, the Gr1 a1Neu mouse is incapable of producing a functional GSR protein. (66) Although the mouse does not show hemolytic anemia, (65) which is implicated as a result of a defect in the erythrocyte GSR, proximal tubule injury is induced more severely by a redox cycling toxicant, diquat, compared with wild-type mice. (67) Unexpectedly, however, Gr1 a1Neu mice are less susceptible to acute lung injury from continuous exposure to 95% oxygen, (68) although GSR is present predominantly in lung epithelia. (62) There remains ambiguity concerning what is responsible for the 10% NADPH-dependent GSSG reducing activity in Gr1 a1Neu mice. In mammal cells, redox homeostasis of many cellular processes is maintained by thioredoxin (Trx) as well as by glutathione systems. (69, 70) NADPH supplies reducing equivalents for these redox systems via pyridine nucleotide disulfide oxidoreductases that include Trx reductase and GSR. (71) These reductases are structurally similar and appear to have evolved from the same ancestral gene, although Trx-reductase has an essential C-terminal extension with a selenocysteine residue at the penultimate position. (72) Pretreatment with aurothioglucose, a Trx reductase inhibitor, in fact exacerbates the effects of hyperoxia on lung injuries in mice. This result suggests that Trx/Trx reductase has a more important protective function than GSR in hyperoxic lung injury.
Recently, a novel pyridine nucleotide disulfide oxidoreductase has been found. The enzyme possesses specificity for both thioredoxin and glutathione and is referred to as thioredoxin/ glutathione reductase. (73) This novel reductase appears to have a role in sperm maturation. (74, 75) Since this enzyme can reduce oxidized GSSG in a similar manner to GSR, it may at least be partly responsible for the remaining GSSG-reducing activity of Gr1 a1Neu mice.
Export of oxidized glutathione and glutathione conju gates via MRP. Depletion of cellular glutathione is mainly caused by exporting GSSG, glutathione S-conjugates, and Snitrosoglutathione. The export of these compounds is mediated by a subset of proteins belonging to the ATP-biding cassette transporter (ABC transporter) protein superfamily that contains 49 members in humans. (76) Several members of the ABC subfamily C, also known as the multidrug resistance regulator subfamily, appear to mediate the export of them.
(6) MRP1 (gene symbol ABCC1) has been extensively characterized among the MRP members and provides knowledge of the molecular mechanisms and its physiological functions concerning the transport of glutathione and glutathione conjugates.
(77) Overexpression of MRP1 is found in multidrug-resistant cancer cells and causes the failure of chemotherapy. Certain forms of MRP2 (ABCC2), MRP4 (ABCC4), MRP5 (ABCC5), MRP6 (ABCC6), MRP8 (ABCC8), and CFTR (ABCC7; cystic fibrosis transmembrane conductance regulator) also transport some glutathione-related compounds, but different physiological functions from MRP1 are implied. Some glutathionerelated compounds can also be transported by members of the solute carrier (SLC) superfamily of proteins. (77) Extracellular metabolism of glutathione by γ glutamyl transferase (GGT). γ-Glutamyl transferase (GGT) is localized at the cellular surface in the form of a membrane protein and enhances cellular glutathione synthesis by increasing the availability of component amino acids, especially cysteine.
(1) Extracellular glutathione is hydrolyzed to its γ-glutamyl moiety and cysteinylglycine, which is further cleaved into cysteine and glycine. The released amino acids are taken up by corresponding transporters and reused by cells. GGT also catalyzes transferring reaction of γ-glutamyl moieties from glutathione and other γ-glutamyl compounds to acceptor molecules.
GGT is one of the most widely used clinical indicators of tissue damage. The best-characterized form is GGT1, which is an extracellular enzyme that is anchored to the plasma membrane of the cells. The human genome contains additional related genes. Systematic designation has been proposed for the human GGT family in collaboration with the HUGO Gene Nomenclature Committee. (78) The family includes genes encoding full-length proteins, GGT1 to GGT8P, and light chain only, GGTLC1 to GGTLC5P. Hereafter, this paper will use this nomenclature in reference to the GGT family genes.
GGT deficiency in humans is rare and has been reported in less than 10 cases worldwide, but no mutations are known either in GGT1 or in other family members. Other than a low GGT activity, these patients commonly have glutathionuria, increased plasma glutathione levels and the presence of γ-glutamylcysteine and cysteine in urine. (79) Three of the patients show deficiencies in LTD4 that are generated by a GGT-catalyzed reaction from the primary cysteinyl leukotriene LTC4. (80) There are now four mouse models of GGT deficiency: GGT enu1 mice generated by treatment with N-ethyl-N-nitrosourea and found to have a point mutation within the protein coding region of GGT1; (81) dwarf grey (dwg) and dwg (Bayer) mutations have been identified in GGT1; (82) and, two genetically modified mice with targeted disruption of GGT1 (83) or GGT5 (84) also have been generated.
In GGT enu1 mice, GGT protein synthesis is prematurely terminated and the enzyme is inactive, (85) which causes an altered redox balance and oxidative stress in tissues of the mouse even under normoxic conditions. (86) Total glutathione content in the liver of GGT enu1 mice is reduced but can be restored by oral supplementation of the cysteine prodrug L-2-oxothiazolidine-4-carboxyate. (87) GGT enu1 mice show an increase in extracellular glutathione in lung lining fluid and are protective against epithelial cell induction of asthma. (88) This suggests that local inhibition of GGT in the lining fluid of lungs may be beneficial in preventing asthma.
The dwg is the result of a spontaneous mutation in mice. Homozygous (dwg/dwg) mice are characterized by a gray coat, a smaller body size, and the development of cataracts by 3-4 weeks after birth. Bayer was confirmed as allelic with the dwg mutation. These abnormalities observed in dwg/dwg and dwg Bayer /dwg Bayer mice resemble those of GGT1-knockout mice. (83) Analyses of the genomic DNA show that 13 nucleotides on exon 7 of the GGT1 are deleted in dwg/dwg mice while 46.7 kb containing complete coding sequences of GGT1, AI646023 gene, and the first exon of the GGT5 are deleted in dwg
Bayer

/dwg
Bayer mice. (82) GGT1 knockout mice have been reported by Lieberman et al., (83) and the roles of GGT1 in individual organs become evident under various pathophysiological conditions using GGT1-deficient mice. Observed abnormal phenotypes include growth retardation, sexual immaturity, cataract development, and gray coat color. While expression of genes involved in glutathione metabolism, γ-GCS, GSS, and cystathionase are induced concomitantly with the marked decrease in levels of glutathione in the GGT1-deficient mouse liver, antioxidative enzymes, CuZn-and Mn-superoxide dismutase, catalase, and glutathione peroxidase, are not changed. (90) DNA damage accumulates in the organs of mice deficient in GGT1, which is due to decreased redox capacity with low cysteine and GSH. (91) Oral administration of NAC to the GGT1-deficient mice partially restores normal phenotypes, suggesting a role of GGT in the supply of cysteine and GSH homeostasis. A decrease in mitochondrial glutathione is correlated with negative effects on mitochondrial respiration with respect to ATP production. (92) Supplementation of NAC again fully restores mitochondrial GSH and respiratory function. The testes and seminal vesicles of GGT1-knockout mice are reduced in size, and the mice are infertile. (93) Consistent with the significant role of GSH in fertility, the administration of GSH or NAC to these mice completely restores the testis and seminal vesicle size to values comparable to those of wild-type mice, which renders the mutant mice fertile. Skeletal abnormalities and dwarfism is caused by proliferative defectiveness in GGT1-deficient mice. Although cells involved in osteoclast biology do not express GGT1, chondrocytes are reversed by NAC administration. (94) Because purified GGT1 protein, even if in an enzymatically inactive form, activates receptor-mediated osteoclast formation, (95) GGT1 may have additional roles other than the well-known enzymatic activity.
When exposed to 80% oxygen, the GGT1-deficient mice develop diffuse pulmonary injury and die within 8 days. (96) Investigation of the repair mechanism in bleomycin-induced pulmonary fibrosis suggests participation of increased neutrophils and matrix metalloproteinase-9 in the early inflammatory response. (97) When the nephrotoxic effects of cisplatin are examined, wild-type mice suffer from nephrotoxicity of cisplatin, but GGT1-deficient mice show no evidence of nephrotoxicity regardless of NAC supplementation. These results suggest that the nephrotoxicity of cisplatin is caused by metabolic conversion via GGT activity. (98) GGT deficiency in human T and B-lymphocytes appears to enhance the lifetime of GSNO, (99) which is a major reaction product of glutathione with reactive nitrogen oxide species in plasma. This results from increased extracellular glutathione concentrations, and decreased intracellular GSNO breakdown. A decrease in GSH levels in GGT1 deficiency causes a decrease in cytotoxic T lymphocytes and a defect in T cell-dependent immune responses. (100) A few pathological cases suggest that GGT1 is not simply advantageous to animals. For example, when the role of GGT1 in the elimination of methylmercury is investigated, the GGT1-deficient mice excrete methylmercury more rapidly than wild-type mice, but eliminate inorganic mercury with an efficiency that is similar to wild-type mice.
(101) Cataract development in GGT1-deficient mice appears to be a consequence of multiple causes, including exogenous damage (exposure to light), decreased lens glutathione levels, and nutritional effects of low cysteine availability. (102) Other than GGT1, a physiological role of GGT5 is now shown among the GGT family. LTC4 is formed by conjugation of LTA4 with GSH and is converted to LTD4 by removing the glutamyl moiety by GGT activity. Substantial conversion of LTC4 to LTD4 in GGT1-null mice enabled identification of γ-glutamyl leukotrienase, now designated as GGT5, that catalyzes the conversion and other glutathione conjugates. (103, 104) Analyses of GGT5-deficient mice indicate that GGT5 is specifically responsible for LTD4 formation in vivo and attenuation of the acute inflammatory response. (84, 105) Interactions between LTC4 and interleukin 13 signaling pathways are implied using a GGT5-deficient mice model of airway diseas. (106) Perspective Pleiotropic roles have been established for glutathione in cells, but it is difficult to demonstrate the physiological relevance of them in vivo. Technology regarding gene manipulation has enabled analysis of the functions of individual genes in vivo. Application of this technique to genes involved in glutathione metabolism has provided us a clear picture of the functions of glutathione. Here, we have reviewed mainly mice models that have been established by either transgenic expression or by targeted disruption of the genes. Despite precious data obtained from these animals, it is sometimes claimed that overexpression or null mutation is far removed from the physiological state. In this regard, the application of small interfering RNA (siRNA) or small hairpin RNA (shRNA) to animal models makes it possible to finetune gene expression, and, hence, leads to a better understanding of their functions under more physiologic conditions.
